Tajikistan: Latest MSF Updates
- TB Patients in Tajikistan Celebrate New Treatment Access
- Improving Pediatric TB Care in Tajikistan
- A 5-Year-Old Undergoes MDR-TB Treatment in Tajikistan
- Tajikistan: MSF Treats Its Youngest-Ever Patient for Multidrug-Resistant TB
This information is excerpted from MSF’s 2016 International Activity Report.
MSF continued to work with the Ministry of Health to diagnose and treat children and their families affected by drug-sensitive and drug-resistant tuberculosis (DR-TB). In 2016, the promising new drugs bedaquiline and delamanid were used for the first time in Tajikistan—with 17 patients treated with bedaquiline and four with delamanid. The program aimed to treat patients at home wherever possible and demonstrate that comprehensive TB care for children is feasible. MSF also supported the pediatric TB hospital in Dushanbe and the pediatric ward in Machiton hospital. The project treated children who have both TB and HIV, and TB and severe malnutrition. MSF worked with the Ministry of Health to finalize the third version of the pediatric guide for Tajikistan, providing information about best practices for the treatment of children with TB. Since the beginning of the project, 147 patients with TB have been treated.
MSF also ran the Kulob pediatric HIV and family project aiming to reduce morbidity and mortality of children with HIV/AIDS. Since June, the team has assisted 62 children and 17 family members with treatment for opportunistic infections, prevention of mother-to-child transmission of HIV, and nutritional and social support programs.